SL STRATEGIES, LLC

Lobbying for SEQIRUS · pharmaceutical company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $45,000.00 income · posted May 4, 2026

Lobbying activity 2

Budget/Appropriations

Fiscal Year 2027 HHS Appropriations bills

Health Issues

Policies impacting seasonal and pandemic influenza response

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.